Clinical Trial Update: Real-life Pan-HER-blockade With Neratinib

View source ↗

Summary

This clinical trial update reports a completed real-world study of neratinib used for pan-HER blockade in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• neratinib (neratinib)

Snippet

Sponsor: Pierre Fabre Pharma GmbH | Conditions: Breast Neoplasm | Status: COMPLETED